ABDXF vs JNJ: Which Stock is Better?
Side-by-side comparison of Abingdon Health Plc and Johnson & Johnson in 2026
ABDXF
Abingdon Health Plc
$0.07
JNJ
Johnson & Johnson
$218.21
Key Metrics Comparison
| Metric | ABDXF | JNJ | Winner |
|---|---|---|---|
| Market Cap | $13.27M | $525.73B | JNJ |
| P/E Ratio | N/A | 21.10 | JNJ |
| EPS (TTM) | $N/A | $10.34 | JNJ |
| Revenue Growth | 0.3% | 0.1% | ABDXF |
| Gross Margin | 52.6% | 68.4% | JNJ |
Analyze ABDXF
Full quant analysis
Analyze JNJ
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is ABDXF or JNJ a better investment?
Comparing ABDXF and JNJ: Abingdon Health Plc has a market cap of $13.27M while Johnson & Johnson has $525.73B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between ABDXF and JNJ?
ABDXF (Abingdon Health Plc) and JNJ (Johnson & Johnson) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: ABDXF or JNJ?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: ABDXF or JNJ?
ABDXF has higher revenue growth at 0.3% vs 0.1% for JNJ.
Which company is more profitable: ABDXF or JNJ?
Johnson & Johnson (JNJ) has higher gross margins at 68.4% compared to 52.6% for ABDXF.
Which is the larger company: ABDXF or JNJ?
Johnson & Johnson (JNJ) is larger with a market cap of $525.73B compared to $13.27M for ABDXF.
Should I buy ABDXF or JNJ in 2026?
Both ABDXF and JNJ have investment merit. ABDXF trades at $0.07 while JNJ trades at $218.21. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between ABDXF and JNJ stock?
Key differences: Market Cap ($13.27M vs $525.73B), P/E Ratio (N/A vs 21.1x), Revenue Growth (0.3% vs 0.1%), Gross Margin (52.6% vs 68.4%).